Efficacy of tamsulosin for single renal stone after extracorporeal shock wave lithotripsy: a systematic review

Xiao Hu,Hongbing Lu,Feilun Cui,Chao Qin
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.11.035
2015-01-01
Abstract:ObjectiveTo assess the efficacy of tamsulosin for patients with single renal stone after extracorporeal shock wave lithotripsy (ESWL).MethodsDatabases including Pubmed, Embase and Cochrane Library were searched and randomized controlled trials in which tamsulosin were evaluated for single renal stone after ESWL were included. Methodological quality was evaluated for each included study and stone clearance rate and mean expulsion time were assessed.ResultsSeven randomized controlled trials with low methodological quality and 866 patients in total were included. The results of Meta-analysis showed that compared with the blank or placebo group tamsulosin could increase significantly the stone clearance rate for the single renal stone after ESWL at 4 weeks,RR=1.59, 95% confidence interval (1.19, 2.14), and 12 weeks,RR=1.17, 95% confidence interval (1.04, 1.31).Conclusion Compared with blank or placebo group, treatment with tamsulosin 0.4 mg daily after ESWL appears to be effective in assisting stone clearance in patients with single renal calculi. Further more randomized controlled trials with high quality and large samples are encouraged.
What problem does this paper attempt to address?